10-QPeriod: Q3 FY1999

BOSTON SCIENTIFIC CORP Quarterly Report for Q3 Ended Sep 30, 1999

Filed November 15, 1999For Securities:BSX

Summary

Boston Scientific Corporation (BSX) filed its 10-Q report for the period ending September 29, 1999. While the provided text is a directory listing from the SEC's EDGAR system and does not contain the financial details of the filing, it indicates the report's existence and filing date. Investors would typically look to the full 10-Q for crucial information regarding the company's financial performance, operational achievements, and any significant business developments during the third quarter of 1999. This includes revenue growth, profitability metrics, balance sheet strength, and cash flow generation. Without access to the actual financial statements and management discussion within the 10-Q, specific investor-focused insights cannot be extracted. However, the filing itself signifies the company's ongoing compliance with regulatory reporting standards. For a comprehensive understanding, investors should consult the complete document to analyze trends, assess risks and opportunities, and evaluate management's strategic execution.

Key Highlights

  • 1The filing is a Quarterly Report (10-Q) for Boston Scientific Corp (BSX).
  • 2The report covers the period ending September 29, 1999.
  • 3The filing date was November 15, 1999.
  • 4The provided data is a directory listing from the SEC's EDGAR database, not the full financial report.
  • 5Key financial performance indicators, operational updates, and strategic information are expected to be contained within the full 10-Q document.
  • 6This filing demonstrates BSX's adherence to SEC reporting requirements.

Frequently Asked Questions

The primary purpose of this 10-Q filing is to provide investors and the public with an update on Boston Scientific Corp's financial performance and operations for the third quarter of 1999, as required by the Securities and Exchange Commission (SEC).

The provided text is a directory listing from the SEC's EDGAR system. To access the actual financial data, you would need to locate and review the full 10-Q report document itself, likely available through the SEC's EDGAR database by searching for the specific filing.

Investors should look for key financial information such as revenue, net income, earnings per share, cash flows, balance sheet details (assets, liabilities, equity), management's discussion and analysis of financial condition and results of operations, and any significant legal or business developments that could impact the company's future performance.

The filing date of November 15, 1999, indicates when Boston Scientific Corp submitted its 10-Q report to the SEC for the quarter that ended on September 29, 1999. This date is important for understanding the timeliness of the information provided.